of 70 (when to stop is determined by age, PSA values, and health factors) would reduce prostate cancer mortality in Black men (~30% relative reduction) without significantly increasing the rate of overdiagnosis.Conclusions:Black men should obtain information about PSA screening for prostate cancer....
The National Comprehensive Cancer Network (NCCN, v.2.2018) recommends baseline screening beginning at age 45. "African-American men and men with a family history of prostate cancer represent high-risk groups. However, the panel believes that current data are insufficient to definitively inform the b...
New research confirms that the controversial decision by Warren Buffet – the 81-year-old CEO of Berkshire Hathaway – to undergo a blood test screening for prostate cancer despite his age is hardly unusual. Despite recommendations in 2008 from the United States Preventive Services Task Force agains...
Selection of treatment for a patient with prostate cancer is often based on age and life expectancy. However, life expectancy estimates are often calculated solely on the basis of chronological age, overlooking comorbid conditions and their severity, whi
Prostate cancer screening based on prostate-specific antigen (PSA) testing has been a matter of controversy. Although screening for prostate cancer was effective in reducing mortality, it resulted in overdiagnosis, which translated into unnecessary treat
g: A decision guide Prostate cancer screening: A decision guideProstate cancer screening: A decision guideMyers, Ronald E
In the ERSPC trial, the prostate cancer mortality rate ratio in the screening vs control group among men 70 years and older at randomization was 1.17 (95% CI, 0.82-1.66); however, a statistical test found no significant heterogeneity across age groups. In the PLCO trial, the analogous rate...
screening; rather, they are a statement forinformed or shared decision making. More clearly thanin 1997 and 2001, these guidelines state that there aredef i nite uncertainties regarding the eff i cacy of prostatecancer screening, there are known risks associated withit, and there may be a ...
In 2012, the Veterans Health Administration (VHA) implemented guidelines seeking to reduce PSA-based screening for prostate cancer in men aged 75 years and older. OBJECTIVES To reduce the use of inappropriate PSA-based prostate cancer screening among men aged 75 and over. SETTING The Veterans Affa...
et al. The impact of recent screening recommendations on prostate cancer screening in a large health care system. J. Urol. 191, 1737–1742 (2014). Article PubMed Google Scholar Frendl, D. et al. Impact of guidelines on prostate cancer screening in a population-based setting, 2000-2014...